Remimazolam vs Desflurane for General Anesthesia for Ablation of Arrhythmia
NCT ID: NCT05486377
Last Updated: 2023-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
96 participants
INTERVENTIONAL
2022-08-02
2023-05-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Flumazenil on the Emergence Delirium
NCT05681377
Comparison of the Effect of Remimazolam With Sevoflurane on Postanesthetic Shivering
NCT05523037
Dose of Remimazolam in Children for Intubation
NCT06170918
Comparison of Emergence Delirium: Remimazolam vs Sevoflurane Anesthesia
NCT06214117
Effect of Remazolam on Anesthesia Recovery in Patients Undergoing Fundus Surgery
NCT06205719
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remimazolam
General anesthesia with remimazolam-remifentanil TIVA.
Remimazolam besylate
Remimazolam besylate TIVA
Desflurane
General anesthesia with maintaining with desflurane (induction:PPF, remifentanil CIV)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remimazolam besylate
Remimazolam besylate TIVA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission for General anesthesia for RFCA or cryoablation procedure
Exclusion Criteria
* Acute alcoholic intoxication state
* Coma or shock state due to other condition than heart problem.
* Acute narrow-angle glaucoma
20 Years
105 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
In-Ae Song
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul national university Bundang hospital
Seongnam, Province (optional), South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yim S, Choi CI, Park I, Koo BW, Oh AY, Song IA. Remimazolam to prevent hemodynamic instability during catheter ablation under general anesthesia: a randomized controlled trial. Can J Anaesth. 2024 Aug;71(8):1067-1077. doi: 10.1007/s12630-024-02735-z. Epub 2024 Apr 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-2205-757-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.